RDD Pharma

About

Funding history · 5 rounds · $17.0M total

Q&A

What is RDD Pharma's primary focus?

RDD Pharma is a specialty drug company focused on developing targeted pharmacological treatments for anorectal diseases such as anal fissures, fecal incontinence, and pruritus ani, and gastrointestinal disorders.

When was RDD Pharma founded?

RDD Pharma was founded in 2008.

What is RDD Pharma's core technology?

RDD Pharma's core technology involves repurposing existing drugs and combining them with proprietary drug-delivery methods.

Who are the lead investors in RDD Pharma's Seed round?

In November 2010, RDD Pharma raised $351,000 in a Seed round with lead investors. Arie Giniger.

Who led RDD Pharma's A Round funding?

In July 2012, RDD Pharma secured $7,150,000 in an A Round, led by.

Which investors participated in RDD Pharma's B Round?

In November 2017, RDD Pharma raised $9,500,000 in a B Round, with lead investors.

What is the total amount of funding RDD Pharma has raised?

RDD Pharma has raised a total of $17,000,000 across its funding rounds.

Who is the Chief Medical Officer and Founder of RDD Pharma?

Nir Barak is the Chief Medical Officer and Founder of RDD Pharma, appointed in April 2008.

Team · 14

Nir Barak

Founder · Chief Medical Officer and Founder

John Temperato

Chief Executive Officer

Howard Rice

VP Pharmaceuticals

Robert Niecestro

Regulatory Advisor

Robert Shleypak

Director, Clinical Operations

Mark A. Sirgo

Chairman of the Board

Nissim Darvish

Director

Michael Rice

Director

Ariel Kamsler

Managing Partner and CFO at Agate Medical Investments, Director

Arie Giniger

Active COB

Erez Chimovits

Board Member

Isaac Israel

VP Business Development at Capital Point, Board Member

Andrew Salzman

Board Member

June Almenoff

Executive Chair of the Board

Sectors & technology